United States · FDA National Drug Code directory
Lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-621_4dc7e065-4484-831d-e063-6294a90aaedc
- Product NDC
- 76420-621
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Lansoprazole
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190120
- Source listing expiry
- 20271231
Source-listed ingredients
- LANSOPRAZOLE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-621-30) · 76420-621-30
- 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-621-60) · 76420-621-60
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (76420-621-90) · 76420-621-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →